According to new research, Biofreeze Pain Reliever reduced delayed onset muscle soreness (DOMS)-induced symptoms of pain by 63 percent more than ice.

DOMS, often observed in athletes, is a common consequence of unaccustomed exercise or overtraining especially with the inclusion of extensive eccentric contractions. The presence of DOMS inhibits muscle activity or motor performance for up to several days following the initiating event.

Researchers at Memorial University of Newfoundland in St. Johns, Canada, completed a study on the effectiveness of two types of cold therapy—ice and Biofreeze® Pain Reliever, a menthol based topical analgesic—on DOMS, according to a press release from Performance Health, which manufactures Biofreeze.